Abstract
INTRODUCTION
Colorectal cancer is one of the most grave public health problems. There are nearly one million cases of colorectal cancer diagnosis worldwide each year. The prevalent incidence and age-adjusted mortality of CRC has keeping on increasing in the recent years in Taiwan. In 2008, the incidence and mortality of CRC has occupied the third place among the common cancers. Etiological studies have attributed more than 85% of CRC to several environmental factors [1, 2] , and in particular meat consumption, cigarette smoking, exposure to carcinogenic aromatic amines, such as arylamines and heterocyclic amines [3] [4] [5] .
In the recent years, investigators have got interested to caveolae to define how these lipid domains participate in the pathogenesis of human cancers and what their possible utility may be for the detection and treatment [6] . Caveolae are vesicular invaginations of the plasma membrane, which has been thought to play a critical role in transcytosis, communication between cell surface membrane receptors and intracellular signaling protein cascades such as apoptosis and tumorigenesis [7, 8] .
Caveolins are the major structural proteins of caveolae and this family contains three members in mammals, Caveolin-1 (Cav-1), Caveolin-2 and Caveolin-3 [7, 9] , in which Cav-1 is the principal structural protein. It has been demonstrated that Cav-1 is down-regulated in sarcoma, lung carcinoma, and ovarian carcinoma [10] [11] [12] . However, elevated expression of Cav-1 has been associated with the metastasis of esophageal squamous cell carcinoma and prostate cancer and negatively correlated with patient survival [13, 14] . These findings indicate that the role of Cav-1 may vary considerably, depending on the tissue involved.
The emerging evidence pointing to the role of Cav-1 in carcinogenesis led us to study whether different alleles of this gene are associated with CRC. Thus, the aims of the current study were to determine the genotypic frequency of six polymorphisms of 4 Yang MD et al, 2010 the Cav-1 gene at C239A (rs1997623), G14713A (rs3807987), G21985A (12672038), T28608A (rs3757733), T29107A (rs7804372), and G32124A (rs3807992), and their association with CRC susceptibility. To the best of our knowledge, this is the largest study carried out to evaluate the contribution of Cav-1 polymorphisms in colorectal oncology.
MATERIALS AND METHODS

Study population and sample collection
The study population consisted of 362 CRC patients and 362 cancer-free control 
Genotyping conditions
Genomic DNA was prepared from peripheral blood leucocytes using a QIAamp Blood Mini Kit (Blossom, Taipei, Taiwan) and further processed according to our 5 Yang MD et al, 2010 previous papers [15] [16] [17] [18] [19] [20] [21] [22] [23] . Briefly, the following primers were used for Cav-1 C239A 
(cut from 298 bp T type into 100+198 bp A type), Cav-1 T29107A (cut from 336 bp A type into 172+164 bp T type), and Cav-1 G32124A (cut from 213+142+67 bp A type into 142+118+95+67 bp T type), respectively.
Statistical analyses
Only those matches with all SNPs data (case/control =362/362) were selected 
RESULTS
The frequency distributions of selected characteristics of CRC patients and controls are shown in Table I . These characteristics of patients and controls are all well matched. None of these differences between groups were statistically significant (P>0.05) ( Table I ). The frequencies of the genotypes for the Cav-1 C239A, G14713A, G21985A, T28608A, T29107A and G32124A between controls and CRC patients are shown in Table II . Genotype distribution of various genetic polymorphisms of Cav-1 G14713A and T29107A were significantly different between CRC and control groups (P=1.6*10 -12 and 3.0*10 -4 , respectively), while those for Cav-1 C239A, G21985A, T28608A and G32124A were not significant (P>0.05) (Table II) . To sum up, the polymorphism of Cav-1 G14713A and T29107A are associated with CRC risk and may be a biomarker for CRC early detection. The representative PCR-based restriction analyses for the Cav-1 G14713A and T29107A polymorphisms were shown in Figure 1 .
The frequencies of the alleles for the Cav-1 C239A, G14713A, G21985A, T28608A, T29107A and G32124A between controls and CRC patients are shown in Table III . The two SNPs of Cav-1 found to be associated with CRC in Table II, G14713A and T29107A, are also found to be associated with higher CRC susceptibility in their allele frequency analysis here. As for other four SNPs, the distributions of their allele frequencies are not significantly different in controls and CRC patients (Table III) .
Considering potential interactions between the two significant SNPs of Cav-1 gene and CRC susceptibility, the risk of CRC related to haplotype distributions of Cav-1 G14713A and T29107A were further analyzed (Table IV) (Table IV) .
Since smoking is the predominant risk factor for CRC, the interaction between Cav-1 genotype and individual smoking habits was also analyzed by stratified individual smoking status (Table V) . We noticed that subjects with the hetero-or homozygous AA for Cav-1 G14713A had higher risks of CRC in both smoker and non-smoker groups, no matter before or after adjusting their age, gender and smoking pack-years. In the case of Cav-1 T29107A, the homozygous AA had lower risks of CRC in both smoker and non-smoker groups. The heterozygous AT of Cav-1 8 Yang MD et al, 2010
T29107A also had protective effects in smoker group. To sum up, there was an obvious interaction between smoking status and Cav-1 genotypes in the CRC susceptibility.
DISCUSSION
Although several investigations have shown that Cav-1 plays a critical role in many tumors [10] [11] [12] [13] [14] , few data are available which consider Cav-1 for genetic predisposition to cancers [24, 25] . In 2004, the inactivation of Cav-1 by mutation models or via reducing its expression was found to involve in the pathogenesis of oral cancer [25] . In that study, the exon 1 and 3 sequences of Cav-1 were investigated in 74 oral squamous cell carcinomas and 15 oral cancer cell lines, and the expression of Cav-1 was examined. It was reported that only five mutations (1 missense and 4 silent mutations) of Cav-1 were identified in so many cases, and they were all found in exon 3 [25] . Since sequencing of exonic and promoter regions had not revealed and variants in Cav-1 that might have been directly involved in any cancer risk, it is reasonable for us to select intronic single nucleotide polymorphisms (SNPs) from the NCBI database, and to evaluate the role of Cav-1 polymorphisms, which have never been reported to be associated with CRC risk.
The main finding of this study is that Cav-1 G14713A (rs3807987) and T29107A (rs7804372) polymorphisms are associated with the susceptibility to CRC (Table II and III), while the other four polymorphisms were not. The combinative analysis about Cav-1 G14713A (rs3807987) and T29107A (rs7804372) showed that when taking G14713A/T29107A GG/TT haplotype as a reference, those with GG/AT or GG/AA were of lower CRC risk, while those with other haplotypes, including AG/TT, AG/AT or AG/AA, AA/TT, AA/AT or AA/AA, were of 1.93-to 3.22-fold higher risk.
The data also supported that A allele of G14713A was risky, and A allele of T29107A was protective. Although these genetic variations do not direct result in amino acid coding change, it is plausible to suspect the alternative splicing, intervention, modification, determination or involvement of these SNPs influence the expression level or stability of the Cav-1 protein.
In our immunohistochemistry detection of tumor tissue from oral cancer patients, taking the distant parts from the same subjects as internal control, we have found that Cav-1 was down-regulated in the tumor sites (unpublished data).
Environmental factors such as cigarette smoking were reported to be closely related to CRC carcinogenesis. In this study, the joint effects of Cav-1 gene and individual smoking behaviors were analyzed, and both significant genetic-environmental interactions were observed in Cav-1 G14713A (rs3807987) and T29107A (rs7804372) ( Table V) . The sample size and similar trends of significant data after age-and behavior-adjustments strengthen the accuracy and reliability of our findings, and the frequencies of Cav-1 polymorphisms variant alleles were similar to those reported in the NCBI website in other Asian population studies.
For instance, the minor A allele frequencies of Cav-1 G14713A are 22.1% in our control group, close to those of 16.7% for Beijing and 22.2% for Tokyo populations in NCBI, which strongly suggest no selection bias for the subject's enrolments in terms of genotypes. The smoking population in our patient group is rather low, so that the data itself and that of matched control group are disadvantageous for us to do the stratified analysis of smoking status (Table V) . We agree that it is important to verify our findings in further larger studies and clarify the role of Cav-1 with more phenotypic and functional evidence in CRC and other cancer. In conclusion, this is the first report to provide evidence for Cav-1 G14713A and T29107A, but not C239A, G21985A, T28608A, or G32124A, were associated with higher susceptibility to CRC.
They both have joint effects with smoking status on CRC susceptibility. The G allele 
